Neuropsychiatric symptoms affect most patients with dementia over the course of the
disease. They include a wide variety of symptoms from apathy and depression to psychosis …

Background Dementia is a clinical syndrome commonly seen in the elderly individuals. With
the prevalence of dementia, the incidence of neuropsychiatric symptoms in dementia …

The root causes of dementia are still largely unclear, and the medical community lacks
highly effective preventive and therapeutic pharmaceutical agents for dementia despite …

Objectives Patients hospitalized with stroke develop delirium at higher rates than general
hospitalized patients. While several medications are associated with existing delirium, it is …

Economics and dementia are interconnected in many ways. There is, for example,
accumulating evidence of the ways in which dementia impacts on the economic status of …

Objectives To evaluate the association between health and social care costs and early start
of anti-dementia medication in a nationwide cohort of Finnish Alzheimer's disease (AD) …

Finding neuroprotective drugs with fewer side effects and more efficacy has become a major
problem as the global prevalence of Alzheimer's disease (AD) rises. Natural drugs have …

Background Mild cognitive impairment (MCI), the early stage of dementia, requires effective
intervention for symptom management and improving patients' quality of life (QoL) …

Blood-to-retina transport across the inner blood–retinal barrier (BRB) is a key determinant of
retinal drug concentration and pharmacological effect. Recently, we reported on the …

Neuropsychiatric symptoms affect most patients with dementia over the course of the
disease. They include a wide variety of symptoms from apathy and depression to psychosis …